United States · FDA National Drug Code directory
DOXEPIN HYDROCHLORIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69315-163_ab05177e-b4a4-4cc5-b950-441858aaa0ca
- Product NDC
- 69315-163
- Form
- CAPSULE
- Composition / generic term
- DOXEPIN HYDROCHLORIDE
- Labeler
- Leading Pharma, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210415
- Source listing expiry
- 20261231
Source-listed ingredients
- DOXEPIN HYDROCHLORIDE — 150 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 PACKAGE (69315-163-01) · 69315-163-01
- 500 CAPSULE in 1 PACKAGE (69315-163-05) · 69315-163-05
- 50 CAPSULE in 1 PACKAGE (69315-163-50) · 69315-163-50
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →